NO933345L - Forbedrede retardsystemer for tidsforsinket frisetting avmedisinske og/eller biologiske aktive bestanddeler fra etdepot-baerermateriale - Google Patents

Forbedrede retardsystemer for tidsforsinket frisetting avmedisinske og/eller biologiske aktive bestanddeler fra etdepot-baerermateriale

Info

Publication number
NO933345L
NO933345L NO93933345A NO933345A NO933345L NO 933345 L NO933345 L NO 933345L NO 93933345 A NO93933345 A NO 93933345A NO 933345 A NO933345 A NO 933345A NO 933345 L NO933345 L NO 933345L
Authority
NO
Norway
Prior art keywords
pct
retard
materials
medicinal
systems
Prior art date
Application number
NO93933345A
Other languages
English (en)
Other versions
NO933345D0 (no
Inventor
Wolfgang Ritter
Rudolf Lehmann
Rainer Sorg
Original Assignee
Henkel Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Kgaa filed Critical Henkel Kgaa
Publication of NO933345L publication Critical patent/NO933345L/no
Publication of NO933345D0 publication Critical patent/NO933345D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/204—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0066—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A61L2300/406—Antibiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/13—Burn treatment
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/31504—Composite [nonstructural laminate]
    • Y10T428/31786—Of polyester [e.g., alkyd, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Gjenstand for oppfinnelsen er i en første utførelses- form anvendelsen av radikaliske reaktive fornetter- komponenter på basis av oleflnisk umettede estere av lavere hydroksykarboksylsyrer og/eller deres oligoraerer for modifisering av depotmaterialer. Særlig retard- systemer, som inneholder medisinske og/eller biologiske aktive bestanddeler i blanding med en bærer ved tids- forsinket avgivelse av aktivbestanddel under praktisk bruk. Fornetterne foreligger derved i applikasjons- formen av retardsystemene som polymerforbindelser og kan derved være anordnet i utstrakt homogen fordeling, men også uregelmessig i retardsystemet henholdsvis depotmaterialet som skal applikeres. Gjenstand for oppfinnelsen er videre retardsystemer inneholdende medisinske og/eller biologisk aktive bestanddeler der systemene er på basis av oligomer- og/eller polymer- forbindelser av lavere hydroksykarboksylsyrer som bærer med forsinket frisetting av aktivbestanddel, hvorved det karakteristiske ligger i at retardsystemene henholdsvis depotmaterialene er modifisert med polymerforbindelser av oleflnisk umettede estere av lavere hydroksykarboksylsyrer og/eller deres oligo- merer.
NO933345A 1991-04-17 1993-09-20 Forbedrede retardsystemer for tidsforsinket frisetting avmedisinske og/eller biologiske aktive bestanddeler fra etdepot-baerermateriale NO933345D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4112464A DE4112464A1 (de) 1991-04-17 1991-04-17 Verbesserte retard-systeme fuer die zeitverzoegerte freigabe medizinischer und/oder biologischer wertstoffe aus einem depot-traegermaterial
PCT/EP1992/000825 WO1992018108A1 (de) 1991-04-17 1992-04-11 Verbesserte retard-systeme für die zeitverzögerte freigabe medizinischer und/oder biologischer wertstoffe aus einem depot-trägermaterial

Publications (2)

Publication Number Publication Date
NO933345L true NO933345L (no) 1993-09-20
NO933345D0 NO933345D0 (no) 1993-09-20

Family

ID=6429738

Family Applications (1)

Application Number Title Priority Date Filing Date
NO933345A NO933345D0 (no) 1991-04-17 1993-09-20 Forbedrede retardsystemer for tidsforsinket frisetting avmedisinske og/eller biologiske aktive bestanddeler fra etdepot-baerermateriale

Country Status (14)

Country Link
US (1) US5538738A (no)
EP (1) EP0580689B1 (no)
JP (1) JP3351523B2 (no)
AT (1) ATE133857T1 (no)
AU (1) AU661303B2 (no)
BR (1) BR9205903A (no)
CA (1) CA2108680A1 (no)
DE (2) DE4112464A1 (no)
DK (1) DK0580689T3 (no)
ES (1) ES2083167T3 (no)
FI (1) FI934569A0 (no)
GR (1) GR3019522T3 (no)
NO (1) NO933345D0 (no)
WO (1) WO1992018108A1 (no)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19646782C2 (de) * 1996-11-13 2000-05-25 Merck Patent Gmbh Bioresorbierbare Polymerisationsprodukte aus strahlungshärtbaren Bindemittelsystemen
US7056893B2 (en) * 1999-03-31 2006-06-06 Insite Vision, Inc. Topical treatment for prevention of ocular infections
GB0007419D0 (en) † 2000-03-27 2000-05-17 Smithkline Beecham Gmbh Composition
CZ294328B6 (cs) * 2002-08-22 2004-11-10 Pliva-Lachema A. S. Biodegradabilní kompozice s prolongovaným uvolňováním biologicky aktivní látky a způsob její výroby
US7544192B2 (en) * 2003-03-14 2009-06-09 Sinexus, Inc. Sinus delivery of sustained release therapeutics
CA2603081C (en) 2005-04-04 2013-09-03 Sinexus, Inc. Device and methods for treating paranasal sinus conditions
CA2614187A1 (en) * 2005-07-15 2007-01-25 Bayer Schering Pharma Aktiengesellschaft Drospirenone containing transdermal drug delivery devices and methods of delivery thereof
US8535707B2 (en) 2006-07-10 2013-09-17 Intersect Ent, Inc. Devices and methods for delivering active agents to the osteomeatal complex
DK2231065T3 (da) 2007-12-18 2021-02-01 Intersect Ent Inc Selvekspanderende anordninger
CA2732355A1 (en) 2008-08-01 2010-02-04 Intersect Ent, Inc. Methods and devices for crimping self-expanding devices
EP2370060B1 (en) 2008-11-27 2017-05-03 B.R.A.I.N. Biotechnology Research and Information Network AG Hydrophobins as surface active proteins as excipients in solid pharmaceutical formulations
EP3103502A1 (en) 2009-05-15 2016-12-14 Intersect ENT, Inc. Expandable devices and methods therefor
EP3636227B1 (en) 2013-03-14 2024-08-28 Intersect ENT, Inc. Systems and devices for treating a sinus condition
TWI503625B (zh) 2013-08-23 2015-10-11 Ind Tech Res Inst 感光性組成物與光阻
CN113679931A (zh) 2015-01-22 2021-11-23 因特尔赛克特耳鼻喉公司 药物涂覆的气囊

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2807132C2 (de) * 1978-02-20 1983-11-03 Battelle-Institut E.V., 6000 Frankfurt Implantierbares Pharmaka-Depot
DE3204504A1 (de) * 1982-02-10 1983-08-18 Henkel KGaA, 4000 Düsseldorf Neue schwerfluechtige mono- und/oder bis-(meth)-acrylate und ihre verwendung
EP0085944B1 (de) * 1982-02-10 1986-04-09 Henkel Kommanditgesellschaft auf Aktien Chirurgische Bindemittelsysteme zum Verkleben von körpereigenem Hartgewebe gewünschtenfalls mit Kunststoff und/oder Metall
DE3716302C2 (de) * 1987-05-15 1996-02-01 Henkel Kgaa Verbesserte resorbierbare Knochenwachse und ihre Verwendung
DE3825211A1 (de) * 1988-07-25 1990-02-01 Henkel Kgaa Verbesserte koerperresorbierbare knochenwachse (iii)
DE3939161A1 (de) * 1989-11-27 1991-05-29 Henkel Kgaa Verbesserte reaktivsysteme und/oder polymermassen fuer den gewebekontakt mit dem lebenden koerper

Also Published As

Publication number Publication date
DE59205311D1 (de) 1996-03-21
DK0580689T3 (da) 1996-06-17
BR9205903A (pt) 1994-07-05
JPH06506672A (ja) 1994-07-28
ES2083167T3 (es) 1996-04-01
DE4112464A1 (de) 1992-10-22
GR3019522T3 (en) 1996-07-31
WO1992018108A1 (de) 1992-10-29
JP3351523B2 (ja) 2002-11-25
EP0580689A1 (de) 1994-02-02
US5538738A (en) 1996-07-23
AU1576092A (en) 1992-11-17
EP0580689B1 (de) 1996-02-07
CA2108680A1 (en) 1992-10-18
AU661303B2 (en) 1995-07-20
NO933345D0 (no) 1993-09-20
ATE133857T1 (de) 1996-02-15
FI934569A (fi) 1993-10-15
FI934569A0 (fi) 1993-10-15

Similar Documents

Publication Publication Date Title
NO933345L (no) Forbedrede retardsystemer for tidsforsinket frisetting avmedisinske og/eller biologiske aktive bestanddeler fra etdepot-baerermateriale
DK88385A (da) Biologisk nedbrydeligt polypeptid samt anvendelse deraf til gradvis frigivelse af laegemidler
DE69328558D1 (de) Pharmazeutisches Präparat zur synergistischen Aktivierung natürlicher Killerzellen
IL112112A (en) Peptides with growth hormone releasing properties and pharmaceutical compositions containing them
TR199700687T1 (xx) Etoksillenmi� ya� asidi esterlerinin kendili�inden em�lsifiye olabilir bile�ikler olarak kullan�m�.
DK0700414T3 (da) Polymersammensætning, absorptionsmaterialesammensætning, dens fremstilling og anvendelse
GB2199328B (en) Use of a 5' untranslated leader sequence of an rna virus to enhance translation
SE9404289D0 (sv) Controlled release
DE69401204D1 (de) Gonadotropin enthaltende gefriergetrocknete troepfen
GB2236122B (en) Water-borne water repellents
DK74187D0 (da) Praeparat til langsom frigivelse samt fremgangsmaade til fremstilling deraf
ATE200184T1 (de) Arzneimittelhaltiges tierfutter
DE59806776D1 (de) Verwendung von redispergierbaren Polymerpulvern oder Polymergranulaten als Bindemittel zur Herstellung von festen pharmazeutischen Darreichungsformen
BR0014503A (pt) Matrizes hìbridas e misturas de matriz hìbrida
DK0609280T3 (da) Humane IL-3 varianter
ES2104133T3 (es) Composiciones cosmeticas o farmaceuticas que contienen glicerofosfolipidos desacilados para uso topico.
KR930005634A (ko) Mk 단백질을 사용하여 세포성장을 억제하는 방법
Schell Nitric oxide's involvement in the biphasic effects of the endothelins on prolactin release.
KR910015302A (ko) 생체내 활성을 갖는 폴리펩티드를 지속적으로 방출시키는 조성물